Axsome Therapeutics, Inc. AXSM
140.85 USD +6.89 (+5.14%)
Nov 10, 2026, 3:00 PM EST
133.87 Day range 142.93
123.00 52-week range 260.19
- YTD
- -22.88%
- 1 year
- +2.21%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 638.50M | 385.69M | 270.60M | 50.04M | 0 | |
| 591.02M | 352.39M | 244.53M | 44.84M | 0 | |
| -166.76M | -280.56M | -231.82M | -179.80M | -124.71M | |
| -183.17M | -287.22M | -239.24M | -187.13M | -130.40M | |
| -3.68 | -5.99 | -5.27 | -4.60 | -3.47 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 322.93M | 315.35M | 386.19M | 200.84M | 86.47M | |
| 689.80M | 568.50M | 588.24M | 331.48M | 87.79M | |
| 601.51M | 511.48M | 397.26M | 221.92M | 72.15M | |
| 215.57M | 191.53M | 186.37M | 94.68M | 49.71M | |
| 88.30M | 57.02M | 190.98M | 109.56M | 15.63M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -93.41M | -128.41M | -145.08M | -116.51M | -108.23M | |
| -480.00K | -270.00K | -582.00K | -53.70M | -308.00K | |
| 101.47M | 57.84M | 331.01M | 284.58M | 11.13M | |
| -480.00K | -270.00K | -582.00K | -702.00K | -308.00K | |
| 7.58M | -70.84M | 185.35M | 114.37M | -97.40M |